Evidence map›Paper›PMID 40457050›Full record

ArticleAnnals of hematology2025

New FDG-PET/CT interpretation criteria (Huaxi criteria) for response assessment in patients with nasal-type extranodal NK/T-cell lymphoma: development and validation.

Li Li, Futao Cui, Rong Tian, Ming Jiang, Liqun Zou, Xin Li, Minggang Su

Abstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Prognostic value of lesion dissemination onQuantitative imaging in medicine and surgery · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li Li *Department of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, Sichuan, 610041, People's Republic of China.
Futao Cui *Department of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, Sichuan, 610041, People's Republic of China.
Rong TianDepartment of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, Sichuan, 610041, People's Republic of China.
Ming JiangDepartment of Oncology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Sichuan, Chengdu, People's Republic of China.
Liqun ZouDepartment of Oncology, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Sichuan, Chengdu, People's Republic of China.
Xin LiDepartment of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, Sichuan, 610041, People's Republic of China.
Minggang SuDepartment of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, Sichuan, 610041, People's Republic of China. suminggang@sina.com.

Funding

National Natural Science Foundation of China 81971653Sichuan Science and Technology Program 2023NSFSC1709Sichuan Science and Technology Program 2023NSFSC1714
6 · The paper itself

Abstract

The Deauville criteria are recommended for PET/CT-based treatment response evaluation in extranodal NK/T-cell lymphoma (ENKTL) but have limited prognostic value. Therefore, we conducted a retrospective study of 340 nasal-type ENKTL patients to develop new criteria (Huaxi criteria) and validate them for assessing therapeutic response and survival outcome. 80% (140/175) of the patients who did not receive any anticancer therapy after the end-of-treatment PET/CT (EOT-PET/CT) and had a progression-free survival > 24 months were randomly selected as subjects for developing Huaxi criteria. On EOT-PET/CT, the SUV

Indexed as

Fluorodeoxyglucose F18Lymphoma, Extranodal NK-T-CellNose NeoplasmsPositron Emission Tomography Computed TomographyAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesYoung AdultFluorodeoxyglucose F18Extranodal NK/T-cell lymphomaPET/CTResponse criteriaResponse evaluation

Identifiers

PMID40457050
PMCPMC12283479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.